|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 61.99 USD | +4.15% |
|
+12.61% | +14.92% |
| 02-06 | Wells Fargo Adjusts Bristol-Myers Squibb PT to $60 From $55, Maintains Equal Weight Rating | MT |
| 02-06 | Citigroup Adjusts Bristol-Myers Squibb PT to $64 From $60, Maintains Neutral Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5d. change | Varia. Jan 1. | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Other Pharmaceuticals | +4.15% | +12.61% | +14.92% | +9.04% | +1.76% | 126B |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- BMY Stock
- Charts Bristol-Myers Squibb Company
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition